Get more replies from employers
Send a job-specific resume in minutes.
Amgen Dun Laoghaire is seeking a Senior Associate, Quality Control - Investigations to own the end-to-end lifecycle of Quality records within QC. The role emphasizes strong technical writing, root cause analysis, and problem-solving while ensuring investigations lead to robust CAPA and compliant processes.
You will collaborate across the QC function, participate in audits, and support change controls as needed, with minimal supervision and broad network engagement.
Career Category Quality Job Description Overview: This job specification outlines the general responsibilities associated with the role of Senior Associate, Quality Control, Investigations at Amgen Dun Laoghaire. The QC Systems team provide support to the QC function for all activities within Amgen’s Quality System associated with QC Deviation Investigations, CAPA records, Testing Results Assessments (TRA) and Change Controls. The successful candidate will own and manage the end-to-end life cycle of Quality records on behalf of Quality Control. The role has a strong focus on technical writing and problem-solving including Root Cause Analysis and 5 Why methodologies. Additionally, the role may involve carrying out additional work functions that are not described in this specification but are associated with the QC support function.
Salary Range 52,756.95 EUR - 71,377.05 EUR
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen